Lisicki Robert
SEC insider (Form 3/4/5 filer). CIK 0001779614. Chief Executive Officer at Zura Bio Ltd (ZURA) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 27, 2025. Located in PONTE VEDRA,, FL.
Companies Lisicki Robert has filed insider reports for
- Zura Bio Ltd (ZURA): Director, Officer, Chief Executive Officer
- Cadrenal Therapeutics, Inc. (CVKD): Director
Lisicki Robert
CIK: 0001779614
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Feb 27, 2025ZURA
Zura Bio Ltd
AwardDirectEmployee Share Option (Right to Buy)
1.2M shares- - Jan 23, 2025CVKD
Cadrenal Therapeutics, Inc.
AwardDirectStock Options
20K shares- - Dec 9, 2024ZURA
Zura Bio Ltd
AwardDirectEmployee Share Option (Right to Buy)
117K shares-
1-3 of 3 transactions